Skip to main content
Year archive

STARSOURCE MULTITRADE LIMITED — 2021 filings

All 31 regulatory filings released by STARSOURCE MULTITRADE LIMITED (506365) in 2021, sourced directly from the official regulator.

31 Filings
2021 Period
2021 filings (31)
Filing Released Lang
Pursuant to the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulation 2015 and Company's Code of Conduct to Regulate, Monitor and Report Trading ....
Regulatory Filings
2021-12-31 English
INTIMATION OF CHANGE IN DIRECTORSHIP AND CHANGE IN COMPOSITION OF COMMITTEES PURSUANT TO REGULATION 30 OF SEBI (LODR) REGULATIONS, 2015
Regulatory Filings
2021-10-29 English
Submission of Un-Audited Financial Results for the quarter and half year ended 30.09.2021
Regulatory Filings
2021-10-29 English
Outcome of Board Meeting held on Friday, 29/10/2021
Regulatory Filings
2021-10-29 English
CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2021 ,inter alia, to consider and approve 1.To consider and ....
Regulatory Filings
2021-10-21 English
Submission of Certificate pursuant to Regulation 74 (5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the Quarter and Half Year ended ....
Regulatory Filings
2021-10-04 English
Intimation of Closure of Trading Window for the quarter ended 30.09.2021
Regulatory Filings
2021-09-29 English
Submission of Scrutinizer''s Report along with Voting Results for the 79TH AGM held on 01.09.2021 at 04 p.m.
Regulatory Filings
2021-09-02 English
Proceedings of the 79th Annual General Meeting held on 01.09.2021 at 04 p.m.
Regulatory Filings
2021-09-01 English
Submission of Annual Report for the Financial Year 2020-2021 pursuant to Regulation of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) (Amendment) ....
Regulatory Filings
2021-08-03 English
This is to inform you that Register of Members (Share Transfer Book) will be closed pursuant to the Regulation 42 (2) to (4) of SEBI (Listing Obligations And Disclosure Requirements) Regulations, ....
Regulatory Filings
2021-07-26 English
Submission of Un-Audited Financial Results for the quarter ended 30.06.2021
Regulatory Filings
2021-07-26 English
Submission of Outcome of Board Meeting held on Monday, 26.07.2021 and declaration of decision of holding AGM for the Financial Year 2020-2021 on Wednesday, 01st September, 2021 through ....
Regulatory Filings
2021-07-26 English
CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2021 ,inter alia, to consider and approve 1.Declaration of ....
Regulatory Filings
2021-07-06 English
Submission of Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30.06.2021
Regulatory Filings
2021-07-01 English
Intimation of Closure of Trading Window for the quarter ended 30.06.2021
Regulatory Filings
2021-06-29 English
Submission of Audited Financial Results for the quarter and year ended 31.03.2021
Regulatory Filings
2021-05-28 English
The Board of Directors in its Meeting held on Friday, 28th May, 2021 at 04:00 p.m. at the Corporate Office of the Company at 3rd Floor, Empire House, 214, Dr. D. N. Road, Fort, Mumbai - ....
Regulatory Filings
2021-05-28 English
CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2021 ,inter alia, to consider and approve This is to inform ....
Regulatory Filings
2021-05-18 English
Submission of Certificate of Non- Applicability of Regulation 24A of SEBI (Listing Obligations and Disclosure Requirement) (Amendment) Regulations, 2018
Regulatory Filings
2021-04-23 English
Submission of Certificate Pursuant to Regulation 40(9&10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 issued by Practising Company Secretary for the period ....
Regulatory Filings
2021-04-12 English
Submission of Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018
Regulatory Filings
2021-04-05 English
Submission of Compliance Certificate for the half-year ended March 31, 2021 pursuant to Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015
Regulatory Filings
2021-04-05 English
Intimation of Closure of Trading Window for the quarter ended 31.03.2021
Regulatory Filings
2021-03-30 English
Dear Sirs, This is to inform you that pursuant to Regulation 30 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, we wish to inform you following matters- ....
Regulatory Filings
2021-01-29 English
Revised outcome for the Board Meeting held on 28.01.2021 - Dear Sir, We would like to inform you that the Board of Directors in its Meeting held on Thursday, 28th January, ....
Regulatory Filings
2021-01-28 English
Submission of Un-Audited Financial Results for the quarter ended 31.12.2020
Regulatory Filings
2021-01-28 English
Dear Sir, We would like to inform you that the Board of Directors in its Meeting held on Thursday, 28th January, 2021 at 04:00 p.m. at the Corporate Office of the Company at 3rd ....
Regulatory Filings
2021-01-28 English
CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2021 ,inter alia, to consider and approve Dear Sir, ....
Regulatory Filings
2021-01-12 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shreeniwas Somani & Shanta Somani
Regulatory Filings
2021-01-05 English
Submission of Certificate pursuant to Regulation 74(5) for the period from 01/10/2020 to 31/12/2020
Regulatory Filings
2021-01-04 English